beta

CWBR

CohBar, Inc.

Cwbr

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Pasadena, CA.

Market Cap: 81.5 Million

Primary Exchange: NASDAQ

Website: http://www.cohbar.com

Shares Outstanding: 42.9 Million

Float: 28.8 Million

Dividend: (%)

Beta: 1.1839406210342

Sector: Health Technology

Industry: Biotechnology

Short Interest (Jan 12, 2018): 4.27 Thousand

Ethical Flags

Animal testing

Longest drawdown: 1198 trading days

From: 2018-06-12 To: 2019-11-12

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud